Novel tretinoin formulations: A drug-in-cyclodextrin-in-liposome approach

Journal of Liposome Research

Volumn 23, Issue 3, 2013, Pages 211-219

  Ascenso, Andreia ^a   Cruz, Mariana ^b   Euletério, Carla ^a   Carvalho, Filomena A ^a   Santos, Nuno C ^a   Marques, Helena C ^a   Simões, Sandra ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Atomic force microscopy; Dimethyl cyclodextrin; Photon correlation spectroscopy Laser Doppler anemometry; Tretinoin; Ultradeformable vesicles

Indexed keywords

CYCLODEXTRIN; LIPOSOME; RETINOIC ACID;

ANEMOMETRY; ARTICLE; ATOMIC FORCE MICROSCOPY; COLORIMETRY; CONCENTRATION (PARAMETERS); DISPERSION; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID VESICLE; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SURFACE CHARGE; SUSPENSION; TOPOGRAPHY; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; BETA-CYCLODEXTRINS; DRUG CARRIERS; DRUG STABILITY; LIPOSOMES; MICROSCOPY, ATOMIC FORCE; PARTICLE SIZE; TRETINOIN;

EID: 84880463944     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2013.788026     Document Type: Article

References (47)

1. Ascenso A. (2008). Formulação de um gel de complexo tretino?́na dimetil-beta-ciclodextrina para aplicação tópica. Master, FFUL.
2. Ascenso A, Cabral Marques H. (2009). Acne in the adult. Mini-Rev Med Chem 9:1-10.
3. Ascenso A, Guedes R, Bernardino R, et al. (2011). Complexation and full characterization of the tretinoin and dimethyl-beta-cyclodextrin complex. Aaps Pharmscitech 12:553-63.
4. Becirevic-Lacan M, Skalko N. (1997). Hydrocortisone-cyclodextrin complex complexation methods and complex incorporation in liposomes. STP Pharm Sci 7:343-7.
5. Bharwaj V, Shukla V, Singh A, et al. (2010). Transfersomes ultra flexible vesicles for transdermal delivery. Int J Pharm Sci Res 2:40-2.
6. Bryant G, Thomas JC. (1995). Improved particle size distribution measurements using multiangle dynamic light scattering. Langmuir 11:2480-5.
7. Cevc G. (1997). Drug delivery across the skin. Expert Opin Inv Drugs 6: 1887-937.
8. Cevc G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56:675-711.
9. Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226-32.
10. Cevc G, Schatzlein A, Richardsen H. (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta-Biomembranes 1564:21-30.
11. Cevc G, Vierl U. (2010). Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Rel 141:277-99.
12. Cirri M, Bragagni M, Mennini N, Mura P. (2012). Development of a new delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for ketoprofen topical delivery. Eur J Pharm Biopharm 80:46-53.
13. Domingues MM, Santiago PS, Castanho MARB, Santos NC. (2008). What can light scattering spectroscopy do for membrane-active peptide studies? J Peptide Sci 14:394-400.
14. Dragicevic-Curic N, Gräfe S, Gitter B, et al. (2010). Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J Pharm 384:100-8.
15. El Maghraby GM, Barry BW, Williams AC. (2008). Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34:203-22.
16. El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164-72.
17. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. (2006). Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm 322:60-6.
18. Fatouros DG, Antimisiaris SG. (2002). Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: a study with prednisolone, diazepam, and griseofulvin. J Coll Interface Sci 251:271-7.
19. Fatouros DG, Hatzidimitriou K, Antimisiaris SG. (2001). Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release. Eur J Pharm Sci 13:287-96.
20. Gillet A, Grammenos A, Compère P, et al. (2009). Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome. Int J Pharm 380:174-80.
21. Honeywell-Nguyen PL, Bouwstra JA. (2003). The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J Control Rel 86:145-56.
22. Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as tools for transdermal and dermal delivery. Drug Discov Today: Technol 2: 67-74.
23. Hoo C, Starostin N, West P, Mecartney M. (2008). A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions. J Nanoparticle Res 10:89-96.
24. Ioele G, Cione E, Risoli A, et al. (2005). Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int J Pharm 293:251-60.
25. Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Indust Pharm 29:1013-26.
26. Lautenschläger H. (2006). Liposomes. In: Barel AO, Paye M, Maibach HI, eds. Handbook of cosmetic science and technology. Boca Raton: CRC Press Taylor & Francis Group, 155-63.
27. Loukas YL, Vraka V, Gregoriadis G. (1998). Drugs, in cyclodextrins, in liposomes: a novel approach to the chemical stability of drugs sensitive to hydrolysis. Int J Pharm 162:137-42.
28. Loureiro KD, Kao KK, Jones KL, et al. (2005). Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Gen Part A 136A:117-21.
29. Maestrelli F, Gonzalez-Rodriguez ML, Rabasco AM, Mura P. (2005). Preparation and characterisation of liposomes encapsulating ketoprofen- cyclodextrin complexes for transdermal drug delivery. Int J Pharm 298:55-67.
30. Manconi M, Sinico C, Caddeo C, et al. (2011). Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm 412:37-46.
31. Manconi M, Sinico C, Valenti D, et al. (2006). Niosomes as carriers for tretinoin. Int J Pharm 311:11-19.
32. Manconi M, Valenti D, Sinico C, et al. (2003). Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 260:261-72.
33. McCormack B, Gregoriadis G. (1994). Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target 2:449-54.
34. Montassier P, Duchêne D, Poelman M-C. (1998). In vitro release study of tretinoin from tretinoin/cyclodextrin derivative complexes. J Incl Phenom Macro Chem 31:213-18.
35. Oommen E, Tiwari SB, Udupa N, et al. (1999). Niosome entrapped b-cyclodextrin methotrexate complex as a drug delivery system. Indian J Pharmacol 31:279-84.
36. Ourique AF, Melero A, Silva CDBD, et al. (2011). Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur J Pharm Biopharm 79:95-101.
37. Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. (2008). Tretinoinloaded nanocapsules: preparation, physicochemical characterization, and photostability study. Int J Pharm 352:1-4.
38. Piel G, Piette M, Barillaro V, et al. (2006). Betamethasonein- cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics. Int J Pharm 312:75-82.
39. Scheinfeld N. (2006). Schools of pharmacology: retinoid update. J Drugs Dermatol 5:921-2.
40. Simões S. (2001). Veiculação transdérmica de fármacos: III. Promotores de transporte transdérmico de fármacos. Revista Brasil Cl?́n Terapêutica 27:257-74.
41. Simões S, Marques C, Cruz ME, Figueira Martins MB. (2009). Antiinflammatory effects of locally applied enzyme-loaded ultradeformable vesicles on an acute cutaneous model. J Microencapsul 26: 649-58.
42. Simões S, Tapadas J, Marques C, et al. (2005a). Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. Eur J Pharm Sci 26: 307-17.
43. Simões SI, Delgado TC, Lopes RM, et al. (2005b). Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in transfersomes. J Control Rel 103:419-34.
44. Sinico C, Manconi M, Peppi M, et al. (2005). Liposomes as carriers for denual delivery of tretinoin: in vitro evaluation of drug penneation and vesicle-skin interaction. J Control Rel 103:123-36.
45. Skalko N, Brandl M, Bećirević-Laćan M, et al. (1996). Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison. Eur J Pharm Sci 4:359-66.
46. Tashtoush BM, Jacobson EL, Jacobson MK. (2007). A rapid HPLC method for simultaneous determination of tretinoin and isotretinoin in dermatological formulations. J Pharm Biomed Anal 43:859-64.
47. van den Bergh BAI, Wertz PW, Junginger HE, Bouwstra JA. (2001). Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 217:13-24.